Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Evidence-Based Complementary and Alternative Medicine : Ecam|February 10, 2022
Network Pharmacology- and Molecular Docking-Based Identification of Potential Phytocompounds from <i>Argyreia capitiformis</i> in the Treatment of InflammationAhmad J Obaidullah, Mohammed M Alanazi, Nawaf A Alsaif, et al.
Bioorganic Chemistry|May 21, 2021
Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding siteIbrahim H Eissa, Mohammed A Dahab, Mohamed K Ibrahim, et al.
RSC Advances|April 28, 2022
Immunoinformatics-guided design of a multi-epitope vaccine based on the structural proteins of severe acute respiratory syndrome coronavirus 2Ahmad J Obaidullah, Mohammed M Alanazi, Nawaf A Alsaif, et al.
Bioorganic & Medicinal Chemistry|September 3, 2021
Identification of new [1,2,4]triazolo[4,3-a]quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, anticancer evaluation, and in silico studiesNawaf A Alsaif, Mohammed S Taghour, Mohammed M Alanazi, et al.
Molecular Diversity|August 30, 2021
Design, synthesis and molecular docking of new [1,2,4] triazolo[4,3-a]quinoxaline derivatives as anticancer agents targeting VEGFR-2 kinaseNawaf A Alsaif, Alaa Elwan, Mohammed M Alanazi, et al.
Bioorganic Chemistry|November 4, 2020
Antitumor activity, multitarget mechanisms, and molecular docking studies of quinazoline derivatives based on a benzenesulfonamide scaffold: Cell cycle analysisAdel S El-Azab, Alaa A-M Abdel-Aziz, Nawaf A AlSaif, et al.
Bioorganic Chemistry|March 15, 2021
New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesisNawaf A Alsaif, Mohammed A Dahab, Mohammed M Alanazi, et al.
RSC Advances|May 2, 2022
New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with <i>in silico</i> docking, ADMET, toxicity, and DFT studiesMohammed M Alanazi, Hazem Elkady, Nawaf A Alsaif, et al.
Plants (Basel, Switzerland)|April 30, 2021
Deeper Insights on <i>Cnesmone javanica</i> Blume Leaves Extract: Chemical Profiles, Biological Attributes, Network Pharmacology and Molecular DockingAhmad J Obaidullah, Mohammed M Alanazi, Nawaf A Alsaif, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 30, 2021
Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: design, synthesis, and <i>in silico</i> studiesMohammed M Alanazi, Elwan Alaa, Nawaf A Alsaif, et al.
Pageof 5